Atypical signaling defects prevent IL-2 gene expression in lpr/lpr CD4-CD8- cells

H E Liang1, Y P Hsueh, C C Wu

  • 1Institute of Molecular Biology, Academia Sinica, National Yang-Ming University, Taipei, Taiwan ROC.

Insights

Double negative (DN) T cells in MRL-lpr/lpr mice show impaired IL-2 gene expression due to faster mRNA degradation and reduced promoter activation. This defect involves MAP kinase and JNK signaling inactivation, impacting AP-1 and NF-AT activity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • MRL-lpr/lpr mice possess CD4-CD8- (double negative, DN) T cells exhibiting a nonresponsive phenotype.
  • Understanding the molecular basis of impaired Interleukin-2 (IL-2) gene expression in these cells is crucial.

Purpose of the Study:

  • To investigate the correlation between extremely low IL-2 gene expression and specific signaling pathway inactivation in DN T cells from MRL-lpr/lpr mice.
  • To elucidate the molecular defects underlying the nonresponsiveness of lpr DN T cells.

Main Methods:

  • Analysis of IL-2 production and restoration capacity in lpr DN cells compared to normal T cells.
  • Assessment of mitogen-activated protein (MAP) kinase and c-Jun N-terminal kinase (JNK) activation upon T-cell stimulation.
  • Quantification of IL-2 mRNA stability.
  • Evaluation of transcriptional element binding activities (AP-1, NFAT) on the IL-2 promoter.

Main Results:

  • lpr DN T cells demonstrated significantly reduced IL-2 production that could not be rescued by standard augmentation signals.
  • Activation of MAP kinase and JNK pathways was attenuated in lpr DN cells.
  • IL-2 mRNA exhibited increased degradation rates in lpr DN cells.
  • Suppression of AP-1 and NFAT binding activities was observed on the IL-2 promoter in lpr DN T cells.

Conclusions:

  • The extremely low IL-2 production in lpr DN T cells results from a combination of accelerated mRNA instability and impaired IL-2 gene promoter activation.
  • Defects in MAP kinase and JNK signaling contribute to the reduced activation of AP-1 and NFAT, leading to suppressed IL-2 gene transcription.